Revista Latinoamericana de Microbiología

Contenido por año, Vol. y Num.

Índice de este artículo

Información General

Instrucciones para Autores

Mensajes al Editor


>Revistas >Revista Latinoamericana de Microbiología >Año 2006, No. 3-4

Lopez-Roa RI, Fafutis-Morris M, Matsuoka M
A drug resistant leprosy case detected by DNA sequence analysis from a relapsed Mexican leprosy patient
Microbiología 2006; 48 (3-4)

Idioma: Inglés
Referencias bibliográficas: 15
Paginas: 256-259
Archivo PDF: 126.80 Kb.

Texto completo


A skin biopsy sample was obtained from a relapsed lepromatous leprosy patient from the central area of Mexico. Genes associated with resistance to anti-leprosy drugs were analyzed by DNA sequence assay. A single nucleotide substitution was found at codon 53 (ACC→GCC) in the folP gene, which is known to confer dapsone resistance. No mutations in the rpoB and gyrA, which indicate resistance to rifampicin and fluoroquinoles, were detected. This is the first reported case of dapsone resistant leprosy in Mexico in which the cause of the resistance is shown at genomic level. Evaluation of drug resistance by identifying known mutations in these genes by PCR is simple and reliable. Testing for resistance to anti-leprosy drugs should be performed in relapses or intractable cases for a better outcome.

Palabras clave: Leprosy, Mycobacterium leprae, drug resistance, genomic mutation, dapsone.


  1. Cambau, E., E. Perani, et al. 1997. Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae. Lancet 349(9045):103-4.

  2. Dela Cruz, E., R. V. Cellona, et al. 1996. Primary dapsone resistance in Cebu, The Philippines; cause for concern. Int J Lepr Other Mycobact Dis 64(3):253-6.

  3. Grosset, J. H., C. C. Guelpa-Lauras, et al. 1989. Study of 39 documented relapses of multibacillary leprosy after treatment with rifampin. Int J Lepr Other Mycobact Dis 57(3):607-14.

  4. Ji, B., E. G. Perani, et al. 1996. Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice. Antimicrob Agents Chemother 40(2):393-9.

  5. Jocobson, R. R. and R. C. Hastings 1976. Rifampin-resistant leprosy. Lancet(4):1304-05.

  6. Lockwood, D. N. (2002). Leprosy elimination-a virtual phenomenon or a reality? British Medical Journal 324(7352):1516-8.

  7. Lopez Roa, R. I. and M. Fafutis Morris 2006. Leprosy in Mexico. Jpn. J. Lepr. 75:51-58.

  8. Maeda, S., M. Matsuoka, et al. 2001. Multi-drug resistant Mycobacterium leprae from patients with leprosy. Antimicrob Agents Chemother 45:3635-39.

  9. Matsuoka, M., Y. Kashiwabara, et al. 2003. A second case of multidrug-resistant Mycobacterium leprae isolated from a Japanese patient with relapsed lepromatous leprosy. Int J Lepr Other Mycobact Dis 71(3):240-3.

  10. Matsuoka, M., Y. Kashiwabara, et al. 2000. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin. Int J Lepr Other Mycobact Dis 68(4):452-5.

  11. Matsuoka, M., L. Zhang, et al. 2004. Genotyping of Mycobacterium leprae on the basis of the polymorphism of TTC repeats for analysis of leprosy transmission. J Clin Microbiol 42(2):741-5.

  12. Ozarmagan, G., M. Sutlas, et al. 2004. Detection of Dapsone Resistant Mycobacterium leprae by DNA Sequence Analysis from a Turkish Relapsed Leprosy Patient. Ist. Tip Fak. Mecmuasi 67(4):153-156.

  13. Pettit, J. H. and R. J. Rees 1964. Sulphone Resistance in Leprosy. An Experimental and Clinical Study. Lancet 19:673-4.

  14. Williams, D. L. and T. P. Gillis (2004). Molecular detection of drug resistance in Mycobacterium leprae. Lepr Rev 75(2):118-30.

  15. Williams, D. L., T. L. Pittman, et al. 2001. Simultaneous detection of Mycobacterium leprae and its susceptibility to dapsone using DNA heteroduplex analysis. J Clin Microbiol 39(6):2083-8.

>Revistas >Revista Latinoamericana de Microbiología >Año2006, No. 3-4

· Indice de Publicaciones 
· ligas de Interes 

Derechos Resevados 2019